COVID-19 and Cancer

In this inaugural Daffodil Centre Flagship Seminar, you will hear from the leading international cancer researchers investigating the 'secondary' impacts of the COVID-19 pandemic on cancer prevention, screening and treatment. With representation across 38 countries, the  COVID-19 and Cancer Global Modelling Consortium (CCGMC) brings together the global modelling community to support decision-making in cancer control both during and after the crisis. 

Hosted by Professor Karen Canfell, Director of the Daffodil Centre and Co-Chair of the CCGMC, the Flagship Seminar series will be formally launched by Dr Elisabete Weiderpass, Director of the International Agency for Research on Cancer (IARC) with an opening address on IARC’s mission and collaboration with the Daffodil Centre.

Join us to hear about the CCGMC’s current research and emerging results from leading members of this global research consortium, including:

Overview of the COVID-19 and Cancer Global Modelling Consortium (CCGMC)

Dr Freddie Bray, IARC, Co-Chair CCGMC

Impact on cancer risk: worldwide review of smoking behavioural changes during the pandemic

Dr Isabelle Soerjomataram, IARC

Dr Peter Sarich, the Daffodil Centre

Impact of disruptions on cancer screening programs using the example of colorectal cancer screening

Dr Iris Lansdorp-Vogelaar, Erasmus University, The Netherlands

Dr Eleonora Feletto, the Daffodil Centre

Review of the impact of COVID-19 on cancer outcomes, and the projected impact of treatment disruptions in Canada

Dr Julia Steinberg, the Daffodil Centre

Dr Talia Malagon, McGill University, Canada

Cervical cancer elimination: the impact of COVID-19 on reaching the WHO global targets

Professor Karen Canfell, the Daffodil Centre

Dr Kate Simms, the Daffodil Centre

Moderated Q&A: What are the implications for cancer control in Australia?

Register for the Event